Please sign in to follow a disease.
New ORS formula could protect diabetic pilgrims from heat stress
NCT ID NCT07618702
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a modified oral rehydration salts (ORS) drink designed for diabetic pilgrims at risk of heat stress and dehydration during the Hajj. The modified ORS has adjusted electrolytes and carbohydrates to avoid raising blood sugar. Researchers will compare it to standard ORS in 200 diabetic adults to see if it maintains hydration and electrolyte balance safely.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Modified oral rehydration salts (ORS) with adjusted electrolytes and carbohydrates
- What this could lead to
- If it works, this could provide a safer rehydration option for diabetic pilgrims during Hajj, reducing heat-related complications.
- What could go wrong
- This is a small, early-stage trial with 200 participants, so results may not apply to all diabetics. The modified ORS may not be as effective as standard ORS for hydration.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 200 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jun 2026
An estimate. Start dates often move.
- Expected to finish
-
Jun 2027
An estimate. End dates often move.
- Lead sponsor
-
A government agency
The lead sponsor is a government body.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 80 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Diabetic pilgrims attending Hajj. * Age between 18 and 80 years. * Willingness to participate and provide informed consent. * Diagnosis of Type 1 or Type 2 Diabetes Mellitus. Exclusion Criteria: * Patients with severe renal failure. * Patients with acute cardiovascular events. * Patients unable to take oral fluids. * Pregnancy or breastfeeding. * Participation in another clinical trial within the last 30 days.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Diabetes mellitus are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Ministry of health
Riyadh, Saudi Arabia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New pill takes aim at stubborn blood sugar
- Gene therapy shots aim to save legs from amputation in diabetes
- New pill takes aim at blood sugar in diabetes
- Can coconut oil and moringa rinses fight gum disease in diabetic kids?
- Can AI-Tailored heat warnings shield chronic disease patients from dangerous temperatures?
- Eye scans as a window to the body: study probes retinal imaging across diseases